Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Emergent BioSolutions Inc (NYSE:EBS)

38.52
Delayed Data
As of Apr 29
 -0.68 / -1.73%
Today’s Change
27.68
Today|||52-Week Range
40.96
-3.72%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Revenue and IncomeNet Revenues63.6M126.1M164.9M168.1M
 
 
 
 
 
Cost of Goods Sold9.4M18.5M31.8M30.3M
 
 
 
 
 
Depreciation And Amortization8.5M8.8M8.6M9.5M
 
 
 
 
 
 
Operating ExpensesGross Income45.7M98.8M124.6M128.3M
 
 
 
 
 
General Expenses72.4M78.2M67.7M78.4M
 
 
 
 
 
Research And Development38.7M40.9M33.0M32.5M
 
 
 
 
 
Total Operating Expenses90.4M105.5M108.0M118.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-26.8M20.6M56.9M49.9M
 
 
 
 
 
Extraordinary Credit0.00808.0K5.9M0.00
 
 
 
Extraordinary Charge-1.6M---9.8M0.00
 
 
 
Interest Expense On Debt2.3M2.3M2.4M2.4M
 
 
 
 
 
Other Expenses100.0K-497.0K602.0K-524.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-29.8M19.6M52.1M47.9M
 
 
 
 
 
Income Taxes-8.3M-5.5M-15.1M-14.5M
 
 
 
 
 
Net Income-21.5M14.1M36.9M33.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS37.9M38.5M38.8M39.1M
 
 
 
 
 
Shares To Calculate EPS Diluted37.9M47.4M47.8M48.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.57$0.32$0.79$0.71
 
 
 
 
 
EPS Diluted-$0.57$0.32$0.79$0.71